Youwei Bi
10PUBLICATIONS
103CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jan 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer.Yufan Liu, Jeannette Nashed, Amy K Barone
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.Michael J Fusco, Sandra J Casak, Sirisha L Mushti
|Aug 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma.Michael I Barbato, Jeannette Nashed, Diana Bradford
Pageof 2
Frequent Collaborators
10 joint publications
Richard Pazdur
6 joint publications
Barbara Scepura
6 joint publications
Paul G Kluetz
5 joint publications
Harpreet Singh
5 joint publications
Nicole Drezner
5 joint publications
Anup K Amatya
5 joint publications
Claudia P Miller
4 joint publications
Pallavi S Mishra-Kalyani
4 joint publications
Yangbing Li
4 joint publications
Yuching Yang
